We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Robotic Technology Unveiled for Automated Diagnostic Blood Draws

By LabMedica International staff writers
Posted on 03 Feb 2026

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience. More...

To help address this challenge, Vitestro (Utrecht, Netherlands), a pioneer in medical robotics for automated diagnostic blood collection, has developed Aletta, the world’s first Autonomous Robotic Phlebotomy Device (ARPD), creating a new standard for how blood draws are performed.

Aletta is designed to autonomously perform routine diagnostic blood collection. The system integrates multimodal imaging, advanced robotics, and artificial intelligence to identify suitable veins, guide needle insertion, and collect blood samples with precision and consistency. Aletta is intended to support phlebotomy departments by addressing staffing constraints, reducing operator‑dependent variability, and standardizing specimen quality while enhancing patient experience.

The new website provides detailed information about Vitestro and its Aletta system, outlining the technology, intended diagnostic applications, and role in modern clinical laboratory and outpatient care settings. The site also features Vitestro’s newly released public video, which walks viewers through each step of the Aletta blood draw process, from arm placement at the device to completion of the procedure. The video offers a practical view of autonomous blood collection in routine clinical settings and marks the first time Vitestro has publicly shared a detailed visual explanation of the technology and its clinical workflow.

Aletta is currently CE marked and is available for clinical use in Europe. Vitestro is pursuing U.S. regulatory authorization alongside broader global expansion, with the goal of advancing autonomous diagnostic blood collection globally.

"Our new website and public video reflect a deliberate step toward more open communication and education,” said Toon Overbeeke, Chief Executive Officer of Vitestro. “As we bring autonomous robotic phlebotomy into routine clinical practice, it is essential that healthcare professionals and patients clearly understand how the technology works and how it integrates into real world care delivery. By making our technology and clinical workflow more visible, we are enabling informed adoption, building confidence, and supporting the responsible establishment of a new standard for diagnostic blood collection.”

Related Links
VItestro


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Thyroid Test
Anti-Thyroid EIA Test
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.